Federal contract award
75F40124C00097
DIRECT 8(A) AWARD OF (1) 12-MONTH BASE PERIOD AND (4) 12-MONTH OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OF
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R425 — Engineering and Technical Services |
| Parent award / vehicle | Not reported |
| Set-aside | 8(A) SOLE SOURCE |
| Pricing type | TIME AND MATERIALS |
| Obligations | $1.9M |
| Current contract value | $1.9M |
| Potential contract value / ceiling | $3.1M |
| Start date | Aug 27, 2024 |
| Current end date | Aug 10, 2027 |
| Potential end date | May 22, 2029 |
| Latest award activity | Aug 12, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 12, 2026 | P00004 | $0 | DIRECT 8(A) AWARD OF (1) BASE PERIOD AND (4) OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OFFICE INFORMATION |
| Aug 7, 2026 | P00003 | $609.0K | DIRECT 8(A) AWARD OF (1) BASE PERIOD AND (4) OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OFFICE INFORMATION |
| Jun 18, 2025 | P00002 | $609.0K | DIRECT 8(A) AWARD OF (1) BASE PERIOD AND (4) OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OFFICE INFORMATION |
| Sep 4, 2024 | P00001 | $0 | DIRECT 8(A) AWARD OF (1) 12-MONTH BASE PERIOD AND (4) 12-MONTH OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OF |
| Aug 27, 2024 | 0 | $649.9K | DIRECT 8(A) AWARD OF (1) 12-MONTH BASE PERIOD AND (4) 12-MONTH OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OF |
Estimated positioning window
May 22, 2028 – Nov 22, 2028
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-05-22 (933 days from calculation)
- +15 points
- 8 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-08-12
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.